Atossa Genetics (ATOS) Starts Presentation at 12th Annual LD Micro Main Event
Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. The company’s innovative therapies and delivery methods can transform breast cancer treatment – with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly disease. Approximately one in eight women and one in 1,000 men will be diagnosed with breast cancer during their lifetime. For more information, visit the company’s website at https://www.atossagenetics.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…







